The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Daniel C. Baumgart

Department of Medicine

Division of Gastroenterology and Hepatology

Charité Medical Centre

Virchow Hospital

Germany

[email]@charite.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Division of Gastroenterology and Hepatology, Charité Medical Centre, Virchow Hospital, Germany. 2005 - 2012
  • Division of Gastroenterology and Hepatology, Department of Medicine, Charité Medical Center - Virchow Hospital, Medical School of Humboldt University of Berlin, Germany. 2009 - 2011
  • Charité Medical Center-Virchow Hospital, Medical School of the Humboldt-Univ. of Berlin, Dept. of Medicine, Division of Gastroenterology and Hepatology, Germany. 2002 - 2011
  • Charité Medical School, Virchow Hospital, Humboldt-University of Berlin, Germany. 2011
  • Charité Medical Center - Virchow Hospital, Department of Medicine, Division of Gastroenterology & Hepatology Medical School of the Humboldt-University of Berlin, Augustenburger Platz 1, Germany. 2010

References

  1. Crohn's disease. Baumgart, D.C., Sandborn, W.J. Lancet (2012) [Pubmed]
  2. Endoscopic surveillance in Crohn's disease and ulcerative colitis: who needs what and when? Baumgart, D.C. Dig. Dis (2011) [Pubmed]
  3. Anti-inflammatory effects of Saccharomyces boulardii mediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis. Thomas, S., Metzke, D., Schmitz, J., Dörffel, Y., Baumgart, D.C. Am. J. Physiol. Gastrointest. Liver Physiol. (2011) [Pubmed]
  4. Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients. Baumgart, D.C., Grittner, U., Steingräber, A., Azzaro, M., Philipp, S. Inflamm. Bowel Dis. (2011) [Pubmed]
  5. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Baumgart, D.C., Bernstein, C.N., Abbas, Z., Colombel, J.F., Day, A.S., D'Haens, G., Dotan, I., Goh, K.L., Hibi, T., Kozarek, R.A., Quigley, E.M., Reinisch, W., Sands, B.E., Sollano, J.D., Steinhart, A.H., Steinwurz, F., Vatn, M.H., Yamamoto-Furusho, J.K. Inflamm. Bowel Dis. (2011) [Pubmed]
  6. CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitis. Baumgart, D.C. Curr. Opin. Investig. Drugs (2010) [Pubmed]
  7. Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis. Baumgart, D.C., Targan, S.R., Dignass, A.U., Mayer, L., van Assche, G., Hommes, D.W., Hanauer, S.B., Mahadevan, U., Reinisch, W., Plevy, S.E., Salzberg, B.A., Buchman, A.L., Mechkov, G.M., Krastev, Z.A., Lowder, J.N., Frankel, M.B., Sandborn, W.J. Inflamm. Bowel Dis. (2010) [Pubmed]
  8. Transient cytokine-induced liver injury following administration of the humanized anti-CD3 antibody visilizumab (HuM291) in Crohn's disease. Baumgart, D.C., Lowder, J.N., Targan, S.R., Sandborn, W.J., Frankel, M.B. Am. J. Gastroenterol. (2009) [Pubmed]
  9. The diagnosis and treatment of Crohn's disease and ulcerative colitis. Baumgart, D.C. Dtsch. Arztebl. Int (2009) [Pubmed]
  10. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Baumgart, D.C., Thomas, S., Przesdzing, I., Metzke, D., Bielecki, C., Lehmann, S.M., Lehnardt, S., Dörffel, Y., Sturm, A., Scheffold, A., Schmitz, J., Radbruch, A. Clin. Exp. Immunol. (2009) [Pubmed]
  11. Tacrolimus (FK506) for induction of remission in refractory ulcerative colitis. Baumgart, D.C., Macdonald, J.K., Feagan, B. Cochrane. Database. Syst. Rev (2008) [Pubmed]
  12. What's new in inflammatory bowel disease in 2008?. Baumgart, D.C. World J. Gastroenterol. (2008) [Pubmed]
  13. The c.1-260C>T promoter variant of CD14 but not the c.896A>G (p.D299G) variant of toll-like receptor 4 (TLR4) genes is associated with inflammatory bowel disease. Baumgart, D.C., Buning, C., Geerdts, L., Schmidt, H.H., Genschel, J., Fiedler, T., Gentz, E., Molnar, T., Nagy, F., Lonovics, J., Lochs, H., Wiedenmann, B., Nickel, R., Witt, H., Dignass, A. Digestion (2007) [Pubmed]
  14. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Baumgart, D.C., Sandborn, W.J. Lancet (2007) [Pubmed]
  15. Inflammatory bowel disease: cause and immunobiology. Baumgart, D.C., Carding, S.R. Lancet (2007) [Pubmed]
  16. Virchow's node. Baumgart, D.C., Fischer, A. Lancet (2007) [Pubmed]
  17. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Baumgart, D.C., Metzke, D., Schmitz, J., Scheffold, A., Sturm, A., Wiedenmann, B., Dignass, A.U. Gut (2005) [Pubmed]
  18. Successful recanalization of a completely obliterated esophageal stricture by using an endoscopic rendezvous maneuver. Baumgart, D.C., Veltzke-Schlieker, W., Wiedenmann, B., Hintze, R.E. Gastrointest. Endosc. (2005) [Pubmed]
  19. Personal digital assistants in health care: experienced clinicians in the palm of your hand?. Baumgart, D.C. Lancet (2005) [Pubmed]
  20. Current biological therapies for inflammatory bowel disease. Baumgart, D.C., Dignass, A.U. Curr. Pharm. Des. (2004) [Pubmed]
  21. Intestinal barrier function. Baumgart, D.C., Dignass, A.U. Curr. Opin. Clin. Nutr. Metab. Care (2002) [Pubmed]
 
WikiGenes - Universities